Manticore Pharmaceuticals Overview

  • Founded
  • 1996

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Manticore Pharmaceuticals General Information


Developer of cobalamin bioconjugates as potential anti-cancer drugs. The company has developed a method to target the delivery of cytotoxic anticancer drugs to tumor cells by using vitamin B12 as delivery vehicle. It has developed fluorescent cobalamin conjugates useful as diagnostic imaging agents in breast cancer surgery and other diagnostic procedures.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Industries
Drug Delivery
Inflabloc Pharmaceuticals
Primary Office
  • 2401 South Foothill boulevard
  • Salt Lake City, UT 84109
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Manticore Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Manticore Pharmaceuticals‘s full profile, request access.

Request a free trial

Manticore Pharmaceuticals Patents

Manticore Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3108168-A1 Thermodynamic cell Active 16-Mar-2020 00000000 0
FR-3108168-B1 Thermodynamic cell Active 16-Mar-2020 00000000

Manticore Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Charles Grissom Ph.D Chairman & Co-Founder
Frederick West Co-Founder
To view Manticore Pharmaceuticals’s complete executive team members history, request access »

Manticore Pharmaceuticals Board Members (1)

Name Representing Role Since
0000000 0000000 00.0 Manticore Pharmaceuticals Chairman & Co-Founder 000 0000
To view Manticore Pharmaceuticals’s complete board members history, request access »